Skip to main content
Clinical Trials/NCT04408300
NCT04408300CompletedNot Applicable

Study of Retinal Vascular Parameters in Patients With Wilson's Disease

Fondation Ophtalmologique Adolphe de Rothschild2 sites in 1 country124 target enrollmentStarted: June 4, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
124
Locations
2
Primary Endpoint
Measurement of the diameter of the arterial lumen (µm)

Study Overview

Brief Summary

The rare disease reference center " Wilson disease and other rare copper-related diseases" of the Rothschild Foundation follows a large number of patients with Wilson's with varying degrees of impairment and located at different times of their care.

Many people with Wilson's disease have a characteristic greenish-brown ring, known as Kayser-Fleischer, appearing at the periphery of the cornea due to a deposit of copper at the Descemet membrane. As a general rule, if the patient is compliant with his treatment, the ring usually disappears within a few years, although it may persist in some patients. However, apart from the stage of diagnosis, and the evolution of the ring, ophthalmological examinations are little used for the follow-up of these patients.

The objective of this study is to describe the retinal parameters, in particular vascular with two new retinal imaging technologies (OCT-A :Optical Coherence Tomography-Angiography , Adaptive optics) in patients with Wilson's disease and to correlate them with the parameters of the usual follow-up of these patients (hepatic assessment, exchangeable plasma copper, neurological scores, compliance, etc.).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Wilson's disease with Ferenci score ≥4

Exclusion Criteria

  • Neurological or behavioral handicap that does not allow for ophthalmological examinations
  • Hepatic decompensation that does not allow for ophthalmological examinations
  • Pregnant or breastfeeding woman

Outcomes

Primary Outcomes

Measurement of the diameter of the arterial lumen (µm)

Time Frame: Enrollment

Adaptive optics

Measuring the width of the Kayser-Fleischer ring

Time Frame: Enrollment

OCT-B scan

Corrected visual acuity measurement

Time Frame: Enrollment

ETDRS

Measurement of the central avascular zone (in µm2)

Time Frame: Inclusion

OCT-A

Measurement of the arterial wall section area (µm²)

Time Frame: Enrollment

Adaptive optics

Intraocular pressure measurement (mmHg)

Time Frame: Enrollment

Measurement of the thickness of the retinal nerve fibers layer (RNFL)

Time Frame: Enrollment

OCT-B

Measurement of the capillary density of the deep plexus (in%)

Time Frame: Enrollment

OCT-A

Measurement of the capillary density of the superficial plexus (in%)

Time Frame: Enrollment

OCT-A

Measurement of photoreceptor density (per mm2)

Time Frame: Enrollment

Adaptive optics

Measurement of wall to lumen ratio (in %)

Time Frame: Enrollment

Adaptive optics

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Network
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Study of Retinal Vascular Parameters in... | Clinical Trial